Showing results (1131-1140 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|February 5, 2026
Survival of Patients Diagnosed With Cancer During the COVID-19 PandemicTodd Burus, Haluk Damgacioglu, Bin Huang, et al.
JAMA Oncology|December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical TrialGeorge Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
JAMA Oncology|November 26, 2025
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical TrialBeung Chul Ahn, Yu Jung Kim, Youngjoo Lee, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
JAMA Oncology|January 17, 2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative ReviewIcro Meattini, Charlotte E Coles, Trine Tramm, et al.
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
JAMA Oncology|January 30, 2025
Urinary DNA Methylation Test for Bladder Cancer DiagnosisIn Gab Jeong, Sung-Cheol Yun, Hong Koo Ha, et al.
JAMA Oncology|December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical TrialAnn H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
JAMA Oncology|December 28, 2023
Rapid Advances in Resectable Non-Small Cell Lung Cancer: A Narrative ReviewHoward Jack West, Jae Y Kim
Pageof 162